These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ketoacidosis Due to Empagliflozin, a Paradigm Shift: Case Report and Review of Literature. Hernandez-Quiles C; Ramirez-Duque N; Acosta-Delgado D Curr Diabetes Rev; 2019; 15(4):259-262. PubMed ID: 30047331 [TBL] [Abstract][Full Text] [Related]
4. Euglycaemic diabetic ketoacidosis in patients using sodium-glucose co-transporter 2 inhibitors. Isaacs M; Tonks KT; Greenfield JR Intern Med J; 2017 Jun; 47(6):701-704. PubMed ID: 28580740 [TBL] [Abstract][Full Text] [Related]
5. Dapagliflozin-Associated Diabetic Ketoacidosis. Chakinala RC; Chang AP; Solanki S; Haq KF; Cho R Am J Ther; 2018; 25(6):e765-e766. PubMed ID: 29672334 [No Abstract] [Full Text] [Related]
6. [Life-threatening ketoacidosis in a 25-year-old woman treated with sodium-glucose cotransporter 2 inhibitor]. Lindberg MJ; Kristensen FB; Yildiz A Ugeskr Laeger; 2016 Nov; 178(47):. PubMed ID: 27908315 [TBL] [Abstract][Full Text] [Related]
7. [Acidosis without marked hyperglycemia : Euglycemic diabetic ketoacidosis associated with SGLT2-Inhibitors]. Valek R; Von der Mark J Med Klin Intensivmed Notfmed; 2017 Mar; 112(2):145-148. PubMed ID: 27221094 [TBL] [Abstract][Full Text] [Related]
8. Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin Use: A Case Report. Brown F; McColl T J Emerg Med; 2018 Jan; 54(1):109-111. PubMed ID: 29157798 [TBL] [Abstract][Full Text] [Related]
9. Empagliflozin-Associated Euglycemic Diabtetic Ketoacidosis. Soni P; Kumar V; Saradna A; Kupfer Y Am J Ther; 2018; 25(6):e740-e741. PubMed ID: 29746292 [No Abstract] [Full Text] [Related]
10. Sodium-glucose co-transport inhibitors: progress and therapeutic potential in type 2 diabetes mellitus. Neumiller JJ; White JR; Campbell RK Drugs; 2010 Mar; 70(4):377-85. PubMed ID: 20205482 [TBL] [Abstract][Full Text] [Related]
11. Low carbohydrate diet while taking dapagliflozin: A case report and review of literature. Paul N; Jonklaas J Diabetes Metab Syndr; 2021; 15(1):361-363. PubMed ID: 33517150 [No Abstract] [Full Text] [Related]
12. [Risk of Euglycemic Diabetic Ketoacidosis Due to Low-carbohydrate Diet While Taking Empagliflozin: a Case Report]. Yamamoto M; Ide N; Kitajima S; Obayashi M; Asada K; Matsushima S; Ito M Yakugaku Zasshi; 2019; 139(11):1479-1483. PubMed ID: 31685745 [TBL] [Abstract][Full Text] [Related]
13. Euglycemic diabetic ketoacidosis caused by dapagliflozin: A case report. Chou YM; Seak CJ; Goh ZNL; Seak JC; Seak CK; Lin CC Medicine (Baltimore); 2018 Jun; 97(25):e11056. PubMed ID: 29923997 [TBL] [Abstract][Full Text] [Related]
14. Euglycaemic diabetic ketoacidosis in a patient with pancreatitis and type 2 diabetes on empagliflozin. Bardhi O; Bloom MD; Sattari M BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35732358 [TBL] [Abstract][Full Text] [Related]
15. Diabetic Ketoacidosis in Patients with Type 2 Diabetes on Sodium-Glucose Cotransporter-2 Inhibitors - A Case Series. Sharma PV; Jobanputra YB; Lewin K; Bagatell S; Lichtstein DM Rev Recent Clin Trials; 2018; 13(2):156-160. PubMed ID: 29542418 [TBL] [Abstract][Full Text] [Related]
16. Euglycaemic diabetic ketoacidosis in a patient with type 2 diabetes started on empagliflozin. Rashid O; Farooq S; Kiran Z; Islam N BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27177938 [TBL] [Abstract][Full Text] [Related]
17. Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus: A case report. Lee IH; Ahn DJ Medicine (Baltimore); 2020 May; 99(21):e20228. PubMed ID: 32481295 [TBL] [Abstract][Full Text] [Related]
18. SGLT2 Inhibitors May Predispose to Ketoacidosis. Taylor SI; Blau JE; Rother KI J Clin Endocrinol Metab; 2015 Aug; 100(8):2849-52. PubMed ID: 26086329 [TBL] [Abstract][Full Text] [Related]
19. Diabetic Ketoacidosis in a Patient with Type 2 Diabetes After Initiation of Sodium-Glucose Cotransporter 2 Inhibitor Treatment. Storgaard H; Bagger JI; Knop FK; Vilsbøll T; Rungby J Basic Clin Pharmacol Toxicol; 2016 Feb; 118(2):168-70. PubMed ID: 26291182 [TBL] [Abstract][Full Text] [Related]
20. Euglycemic Diabetic Ketoacidosis Associated with Empagliflozin Use in the Course of the SARS-Cov-2 Pandemic. Ozer O; Yorulmaz G J Coll Physicians Surg Pak; 2020 Oct; 30(10):110-111. PubMed ID: 33115581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]